Esketamine – July 2024

• Brand names:
  • Spravato®
• Pharmaceutical Company:
  • JANSSEN-CILAG PTY LTD
• Condition/Indication: Treatment resistant depression
• Meeting Date: July 2024
• Public Summary Document (PSD) July 2024 December 2024 PBAC - (PDF 1.1MB)
• Public Summary Document (PSD) July 2024 December 2024 PBAC - (Word 583KB)

Related Public Summary Documents

• Esketamine – December 2024